Navigation Links
Volcano Announces Participation in SATURN Clinical Trial Sponsored by AstraZeneca
Date:5/5/2008

Study represents first inclusion of Volcano Revolution(R) 45 MHz IVUS Imaging Catheter in large-scale pharmaceutical plaque progression trial.

SAN DIEGO, May 5 /PRNewswire-FirstCall/ -- Volcano Corporation (Nasdaq: VOLC), a leading manufacturer and developer of intravascular ultrasound (IVUS), functional measurement (FM) and Optical Coherence Tomography (OCT) products designed to enhance the diagnosis and treatment of coronary and peripheral vascular disease, announced today participation in SATURN (Study of Coronary Atheroma by InTravascular Ultrasound: Effect of Rosuvastatin Versus AtorvastatiN). This marks the first major pharmaceutical trial allowing physicians to use the Volcano Revolution(R) 45 MHz IVUS Imaging catheter as part of the protocol.

SATURN is a 104-week, parallel-group, multicentre, double-blind, Phase IIIb intravascular ultrasound (IVUS) imaging study of approximately 1,300 patients at 170 centres worldwide. This study by AstraZeneca is designed to measure the impact of CRESTOR(TM) (rosuvastatin) 40 mg and atorvastatin (Lipitor(R)) 80 mg on the progression of atherosclerosis in high risk patients. SATURN will compare the effects of these two statins on the ability to decrease progression or induce regression of atherosclerosis, the main cause of cardiovascular disease, following two years of treatment in patients with coronary artery disease.

The SATURN study is chaired by Steve Nissen, M.D., with Steve Nichols, M.D. from the Cleveland Clinic Core Lab as the principle investigator. Under this protocol, physicians enrolling patients may select the Volcano Revolution(R) IVUS catheters as their IVUS catheter of choice.

About Volcano Corporation

Volcano Corporation (NASDAQ: VOLC) offers a
'/>"/>

SOURCE Volcano Corporation
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine technology :

1. Volcano Sponsors First Study Designed to Determine if IVUS Can Identify Patients at Risk for Stent Thrombosis and to Demonstrate the Benefit of IVUS Guidance for Procedural Outcome
2. Anesiva Announces Publication of Phase 3 Zingo(TM) Data in the Journal Pediatrics
3. ISTA Pharmaceuticals Announces New Phase III Clinical Findings to Support Bepreve NDA Filing
4. Innocoll Announces Dosing of First Patient in US Phase 2 Clinical Trial to Investigate CollaRx(R) GENTAMICIN TOPICAL for the Prevention of Diabetic Foot Infections
5. Medarex Announces Presentations at Annual Meeting of the American Society of Clinical Oncology
6. Alexza Announces Positive Phase 1 Results With AZ-007 (Staccato(R) Zaleplon)
7. Nuvelo Announces Positive Proof-of-Concept Data With Anticogulant NU172
8. XTENT Announces First Quarter 2008 Financial Results
9. Neuralstem Announces Issuance of Core Technology Patent in Europe
10. ROXRO PHARMA Announces Positive Clinical Proof of Concept Results for Novel Intranasal Migraine Treatment
11. PulmoBioTech Announces Details of Its Regulatory Approval Experiments

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...e-FirstCall/--QuestDiagnosticsIncorporated(NYSE: D...informationandservices,announcedthatitisscheduledt...nceinNewYorkCity.ThepresentationisscheduledforWedn...uringtheconference,thecompanywillreaffirmits2009gu...ometoexceed18%ofrevenues,anddilutedearningspershar...
(Date:11/24/2009)...rstCall/--AnadysPharmaceuticals,Inc.(Nasdaq: ANDS ...erJaffrayHealthcareConferenceonTuesday,December1,2...heldatTheNewYorkPalaceHotel.SteveWorland,Ph.D.,Pre...anoverviewofAnadysanditsclinicaldevelopmentprogram...illbesimultaneouslywebcastandcanbeaccessedontheInv...
(Date:11/24/2009).../--Inadditiontofamily,friendsandhealth,cancersurvi...nksgivinggratitudelist. ,, "Theyheardthefactsan...onday,sverdictstotaling$103millionindamagesagainst...omennationwidewhohavesuedWyethandPfizerpharmaceuti...pro.Wisneskiandtheothervictimsofhormonetherapyhave...
Breaking Medicine Technology:Quest Diagnostics To Speak At The 21st Annual Piper Jaffray Healthcare Conference 2Anadys Pharmaceuticals to Present at the Piper Jaffray Healthcare Conference 2Maryland Woman Thankful for Wyeth Verdicts 2The Jones Center for Diabetes 26amp 3B Endocrine Wellness Selects Retasure to Enhance Diabetes Care 54138 1The Jones Center for Diabetes 26amp 3B Endocrine Wellness Selects Retasure to Enhance Diabetes Care 54138 2ZyDoc Medical Transcription Completes Acquisition of Administrative Advantage 54135 1ZyDoc Medical Transcription Completes Acquisition of Administrative Advantage 54135 2ZyDoc Medical Transcription Completes Acquisition of Administrative Advantage 54135 3ZyDoc Medical Transcription Completes Acquisition of Administrative Advantage 54135 4ZyDoc Medical Transcription Completes Acquisition of Administrative Advantage 54135 5Astellas Seeks Rigorous Testing and Safety Related Labeling for Anti Rejection Medications 54132 1Astellas Seeks Rigorous Testing and Safety Related Labeling for Anti Rejection Medications 54132 2Astellas Seeks Rigorous Testing and Safety Related Labeling for Anti Rejection Medications 54132 3Astellas Seeks Rigorous Testing and Safety Related Labeling for Anti Rejection Medications 54132 4Astellas Seeks Rigorous Testing and Safety Related Labeling for Anti Rejection Medications 54132 5
..., Colo., Oct. 3 Tapestry,Pharmaceuticals, Inc. (N...ed,a Phase 2 open- label, multi-center study of TP... This is the second Phase 2 trial exploring the,ac...t Phase 2 trial began,earlier this year in advance...available taxanes are not approved for pancreatic ...
...Dose of Estradiol Shown to Be Safe and Effective f...n, WEST PALM BEACH, Fla., Oct. 3 A study present...merican Menopause Society (NAMS),revealed that Div... the,frequency and severity of moderate to severe ...data presented at the meeting found that Divigel(R...
Other Medicine Technology:Tapestry Initiates Phase 2 Trial of TPI 287 for the Treatment of Advanced Pancreatic Cancer 2Tapestry Initiates Phase 2 Trial of TPI 287 for the Treatment of Advanced Pancreatic Cancer 3Tapestry Initiates Phase 2 Trial of TPI 287 for the Treatment of Advanced Pancreatic Cancer 4Tapestry Initiates Phase 2 Trial of TPI 287 for the Treatment of Advanced Pancreatic Cancer 5New Data Reveal Topical Divigel(R) (estradiol gel) 0.1% Significantly Reduces Frequency and Severity of Hot Flashes 2
(Date:11/25/2009)...ological symptoms, study finds , , WEDN...de effects are among the potential problems faced ...re treated with cisplatin-based chemotherapy, a ne...orwegian men treated for unilateral testicular can...w-up survey conducted from 1998 to 2002. , The ...
(Date:11/25/2009)...Newswire-USNewswire/--TheAmericanAssociationforHom...9,"S.2128,whichisdesignedtosubstantiallyimprovetoo...ebillwasintroducedbySen.GeorgeLeMieux(R-Fla.). ,...canAssociationforHomecareoutlinedinits13-pointanti...ressinFebruary.Thoseprovisionsincludecallingforrea...
(Date:11/25/2009)...al cancer also can reverse a rare stomach disorder...he disease, researchers at Vanderbilt University M...se causes thickening of the stomach lining, severe...nemia and swelling in the feet and ankles due to p...stric cancer. Previously, the only effective treat...
(Date:11/25/2009)...sh that mimicked parts of speech colored perceptio...thDay News) -- People can "hear" not only with the...ows. , In fact, sensations on the skin designed...people decipher sounds better, the Canadian scient...whether we could use tactile information in this w...
(Date:11/25/2009)...ace.com, the premier resource for life science car...f the BioForest™ Hotbed Campaign this mornin...) November 25, 2009 -- BioSpace.com, the premier r...unveiled the third edition of the BioForest™...nal campaign is a promotional effort highlighting ...
Breaking Medicine News(10 mins):Health News:American Association for Homecare Endorses New U.S. Senate Bill, the 'Prevent Health Care Fraud Act of 2009' 2Health News:Vanderbilt scientists report first effective medical therapy for rare stomach disorder 2Health News:Your Skin Can Help Your Ears Listen 2Health News:Your Skin Can Help Your Ears Listen 3Health News:BioSpace Showcases Leading Life-Science Companies in the Northwest 2
...d over $6.1 Million for MDA, SAN BERNARDINO, Cali...nnounce that a check for $1,143,000 was presented ...r the recent Labor Day weekend.,Stater Bros. has r...ds from this campaign will be used to send 1,000 c...
...nut allergen, LANDOVER, Md., Sept. 25 Giant Food...r,s Gourmet Dipping Cookies sold in,Giant,s Bakesh...re not,declared on the labels. These products were...is recall, if purchased on or,before September 24,...
...ually to Aid in the Fight Against,Kidney Disease, ...day by the National Kidney Foundation of the Natio...shington area,s business, government,health, and c...ve,auctions, and dancing., WHEN: Saturday, Novemb...
... Science University Cancer Institute researchers h...otherapy for fighting lung cancer tumors in mice, ... in human lung cancers. , The study was presente....D., Ph.D., and colleagues designed the study in o...
...ger, more intensive rehabilitation after bed rest ...Institute for Neuromusculoskeletal Research at the...OU-COM). , According to Brian C. Clark, Ph.D., as...he first to report sex differences in muscle stren...
...otent cells circumvents safety concerns, scientist...ws) -- Researchers report that they have sidestepp...luripotent stem cells from adult cells. , A team o...ich can be produced from adult cells, rather than ...
Other Medicine News:Health News:Stater Bros. Markets Presents $1,143,000 Check to Muscular Dystrophy Association 2Health News:Women recover muscle strength more slowly than men 2Health News:Researchers Report Stem Cell Advance 2Health News:Researchers Report Stem Cell Advance 3Health News:Researchers Report Stem Cell Advance 4
...boratories is a national reference laboratory and ...ch and development. ARUP offers an extensive test ... clinical and anatomic pathology. Owned by the Uni...e more than half of the nation's university teachi...
...boratories is a national reference laboratory and ...ch and development. ARUP offers an extensive test ... clinical and anatomic pathology. Owned by the Uni...e more than half of the nation's university teachi...
...boratories is a national reference laboratory and ...ch and development. ARUP offers an extensive test ... clinical and anatomic pathology. Owned by the Uni...e more than half of the nation's university teachi...
...boratories is a national reference laboratory and ...ch and development. ARUP offers an extensive test ... clinical and anatomic pathology. Owned by the Uni...e more than half of the nation's university teachi...
Medicine Products: